Literature DB >> 8910613

Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.

Y Cao1, R W Ji, D Davidson, J Schaller, D Marti, S Söhndel, S G McCance, M S O'Reilly, M Llinás, J Folkman.   

Abstract

Recently we have identified angiostatin, an endogenous angiogenesis inhibitor of 38 kDa which specifically blocks the growth of endothelial cells (O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C. , Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Cell 79, 315-328; Folkman, J. (1995) Nat. Med. 1, 27-31). Angiostatin was shown to represent an internal fragment of plasminogen containing the first four kringle structures. We now report on the inhibitory effects of individual or combined kringle structures of angiostatin on capillary endothelial cell proliferation. Recombinant kringle 1 and kringle 3 exhibit potent inhibitory activity with half-maximal concentrations (ED50) of 320 nM and 460 nM, respectively. Also, recombinant kringle 2 displays a significant inhibition, although decreased compared with both kringle 1 and kringle 3. In contrast, kringle 4 is an ineffective inhibitor of basic fibroblast growth factor-stimulated endothelial cell proliferation. Among the tandem kringle arrays, the recombinant kringle 2-3 fragment exerts inhibitory activity similar to kringle 2 alone. However, relative to kringle 2-3, a marked enhancement in inhibition is observed when individual kringle 2 and kringle 3 are added together to endothelial cells. This implies that it is necessary to open the cystine bridge between kringle 2 and kringle 3 to obtain the maximal inhibitory effect of kringle 2-3. An increased (<2-fold) inhibitory activity is observed for the kringle 1-3 fragment (ED50 = 70 nM) compared with kringle 1-4 (ED50 = 135 nM). These data indicate that the anti-proliferative activity of angiostatin on endothelial cells is shared by kringle 1, kringle 2, and kringle 3, but probably not by kringle 4 and that more potent inhibition results when kringle 4 is removed from angiostatin. Thus, in view of the variable lysine affinity of the homologous domains, it would appear that lysine binding capability does not correlate with the relative inhibitory effects of the kringle-containing constructs. However, as we also demonstrate, appropriate folding of kringle structures is essential for angiostatin to maintain its full anti-endothelial activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910613     DOI: 10.1074/jbc.271.46.29461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Fight for reputation. Judah Folkman counter-sued Abbott in the legal battle over kringle 5.

Authors:  V Brower
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

Review 2.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

3.  Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.

Authors:  M S Stack; S Gately; L M Bafetti; J J Enghild; G A Soff
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 4.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

5.  Structure-activity relationships of the human prothrombin kringle-2 peptide derivative NSA9: anti-proliferative activity and cellular internalization.

Authors:  Hyun Sook Hwang; Dong Won Kim; Soung Soo Kim
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

6.  ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2.

Authors:  Nathan V Lee; Makoto Sato; Douglas S Annis; Joseph A Loo; Lily Wu; Deane F Mosher; M Luisa Iruela-Arispe
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

7.  Plasminogen fragment K1-3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver.

Authors:  Esther Raskopf; Sevil Gerceker; Annabelle Vogt; Jens Standop; Tilman Sauerbruch; Volker Schmitz
Journal:  Int J Colorectal Dis       Date:  2009-01-27       Impact factor: 2.571

8.  Gene transfer for the treatment of neovascular ocular disease (an American Ophthalmological Society thesis).

Authors:  John Timothy Stout
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.

Authors:  F Magro; F Araujo; P Pereira; E Meireles; M Diniz-Ribeiro; F Tavarela Velosom
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

10.  Fully reduced granulin-B is intrinsically disordered and displays concentration-dependent dynamics.

Authors:  Gaurav Ghag; Lauren M Wolf; Randi G Reed; Nicholas P Van Der Munnik; Claudius Mundoma; Melissa A Moss; Vijayaraghavan Rangachari
Journal:  Protein Eng Des Sel       Date:  2016-03-07       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.